Re-assessment of the high-grade serous ovarian cancer phosphoproteome – Identification of kinase candidates in TCGA tumors for future clinical intervention

Frank Rolfs; Sander R. Piersma; Connie R. Jimenez

doi:10.1016/j.ebiom.2019.02.018

Re-assessment of the high-grade serous ovarian cancer phosphoproteome – Identification of kinase candidates in TCGA tumors for future clinical intervention

Frank Rolfs, Sander R. Piersma, Connie R. Jimenez

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	34-35
Number of pages	2
Journal	EBioMedicine
Volume	41
DOIs	https://doi.org/10.1016/j.ebiom.2019.02.018
Publication status	Published - 1 Mar 2019

Access to Document

10.1016/j.ebiom.2019.02.018

Cite this

Rolfs, F., Piersma, S. R., & Jimenez, C. R. (2019). Re-assessment of the high-grade serous ovarian cancer phosphoproteome – Identification of kinase candidates in TCGA tumors for future clinical intervention. EBioMedicine, 41, 34-35. https://doi.org/10.1016/j.ebiom.2019.02.018

@article{47b2cb34d6694fd58974b5443a1f56ad,

title = "Re-assessment of the high-grade serous ovarian cancer phosphoproteome – Identification of kinase candidates in TCGA tumors for future clinical intervention",

author = "Frank Rolfs and Piersma, {Sander R.} and Jimenez, {Connie R.}",

year = "2019",

month = "3",

day = "1",

doi = "10.1016/j.ebiom.2019.02.018",

language = "English",

volume = "41",

pages = "34--35",

journal = "EBioMedicine",

issn = "2352-3964",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Re-assessment of the high-grade serous ovarian cancer phosphoproteome – Identification of kinase candidates in TCGA tumors for future clinical intervention

AU - Rolfs, Frank

AU - Piersma, Sander R.

AU - Jimenez, Connie R.

PY - 2019/3/1

Y1 - 2019/3/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061637921&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30797713

U2 - 10.1016/j.ebiom.2019.02.018

DO - 10.1016/j.ebiom.2019.02.018

M3 - Comment/Letter to the editor

C2 - 30797713

VL - 41

SP - 34

EP - 35

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

ER -